Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

1.30
Delayed Data
As of Apr 21
 -0.03 / -2.26%
Today’s Change
0.52
Today|||52-Week Range
3.27
-38.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$30.7M

Company Description

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in development and commercialization of OCR-002 (ornithine phenylacetate0 in intravenous and oral formulations. The company was founded by Wu Xiaoyun, John C. Kappes, and Eckard Weber on January 12, 1998 and is headquartered in Palo Alto, CA.

Contact Information

Ocera Therapeutics, Inc.
525 University Avenue
Palo Alto California 94301
P:(650) 475-0158
Investor Relations:
(919) 328-1109

Employees

Shareholders

Mutual fund holders6.22%
Individual stakeholders4.74%
Other institutional36.42%

Top Executives

Linda S. GraisPresident, Chief Executive Officer & Director
Michael ByrnesChief Financial & Principal Accounting Officer
Stan BukofzerChief Medical Officer
Mark CoffinVP-Pharmaceutical Development & Manufacturing
Amy PotthoffVice President-Clinical Operations